
  
    
      
        Introduction_NNP
        Diabetic_NNP nephropathy_NN (_( DNP_NNP )_) is_VBZ a_DT serious_JJ and_CC common_JJ complication_NN of_IN type_NN 1_CD and_CC type_NN 2_CD
        diabetes_NN mellitus_JJ ,_, leading_VBG to_TO end-stage_JJ renal_JJ failure_NN in_IN up_IN to_TO 30_CD %_NN of_IN individuals_NNS with_IN
        diabetes_NN ._. Early_RB abnormalities_NNS of_IN DNP_NNP affect_VB glomeruli_NN and_CC include_VBP an_DT increase_NN in_IN glomerular_NN
        filtration_NN rate_NN ,_, microalbuminuria_NN ,_, glomerular_NN hypertrophy_NN ,_, and_CC thickening_VBG of_IN the_DT glomerular_NN
        basement_NN membrane_NN ,_, followed_VBN by_IN expansion_NN of_IN mesangial_NN extracellular_NN matrix_NN and_CC
        glomerulosclerosis_NNS [_NN 1_CD ,_, 2_CD ]_NN ._. As_IN with_IN most_JJS chronic_JJ degenerative_JJ kidney_NN diseases_NNS ,_, the_DT gradual_JJ
        decline_NN of_IN renal_JJ function_NN at_IN later_JJ stages_VBZ of_IN DNP_NNP is_VBZ invariably_RB associated_VBN with_IN tubular_JJ
        epithelial_NN degeneration_NN (_( TED_NNP )_) ,_, also_RB called_VBN tubular_JJ atrophy_NN ,_, and_CC interstitial_NN fibrosis_NNS (_( IF_IN )_) ,_,
        hallmarks_NNS of_IN degeneration_NN to_TO end-stage_JJ renal_JJ failure_NN [_NN 3_CD ]_NN ._. Pathomechanisms_NNP that_WDT may_MD initiate_VB
        and_CC /_NN or_CC mediate_VB TED_NNP in_IN DNP_NNP remain_VB poorly_RB understood_VBN ._. While_IN glomerular_NN lesions_NNS consistent_JJ
        with_IN human_JJ DNP_NNP have_VBP been_VBN described_VBN in_IN various_JJ mouse_NN models_NNS of_IN diabetes_NN ,_, TED_NNP and_CC IF_IN have_VBP not_RB
        been_VBN described_VBN in_IN diabetic_JJ mice_NNS [_NN 4_CD ]_NN ._.
        Combining_NNP detailed_JJ renal_JJ phenotype_NN analysis_NN with_IN gene_NN expression_NN profiling_VBG of_IN
        hyperglycemic_JJ mouse_NN models_NNS of_IN type_NN 1_CD (_( streptozotocin_NN [_NN STZ_NNP ]_NN )_) and_CC type_NN 2_CD (_( db_NN /_NN db_NN )_) diabetes_NN ,_, we_PRP
        recently_RB reported_VBD that_WDT decreased_VBD mRNA_NN levels_NNS of_IN CD_NNP 36_CD in_IN kidneys_NNS were_VBD strongly_RB correlated_JJ
        with_IN albuminuria_NN [_NN 5_CD ]_NN ._. CD_NNP 36_CD is_VBZ a_DT transmembrane_NN protein_NN of_IN the_DT class_NN B_NNP scavenger_NN receptor_NN
        family_NN and_CC is_VBZ involved_VBN in_IN multiple_JJ biological_JJ processes_VBZ [_NN 6_CD ]_NN ._. CD_NNP 36_CD is_VBZ widely_RB expressed_VBN and_CC
        may_MD interact_NN with_IN multiple_JJ extracellular_NN ligands_NNS ,_, including_VBG thrombospondin-_NN 1_CD (_( TSP-_NNP 1_LS )_) ,_,
        long-chain_JJ free_JJ fatty_NN acids_NNS (_( FFAs_NNP )_) ,_, modified_VBN (_( oxidized_JJ )_) low-density_NN lipoprotein_NN (_( ox-_NN LDL_NNP )_) ,_,
        advanced_VBD glycation_NN end_NN (_( AGE_NNP )_) products_NNS ,_, and_CC collagens_NNS I_PRP and_CC IV_NNP [_NN 6_CD ]_NN ._. CD_NNP 36_CD mediates_NNS
        phagocytosis_NNS of_IN apoptotic_JJ cells_NNS and_CC malaria-parasitized_JJ erythrocytes_NNS [_NN 7_CD ]_NN ._. Furthermore_RB ,_, CD_NNP 36_CD
        mediates_NNS antiangiogenic_JJ activity_NN associated_VBN with_IN endothelial_NN cell_NN apoptosis_NNS induced_VBN by_IN
        TSP-_NNP 1_CD through_IN p_NN 38_CD MAP_NNP kinase_NN (_( MAPK_NNP )_) and_CC caspase_NN 3_CD [_NN 8_CD ]_NN ._. Hyperglycemia-induced_NNP synthesis_NN of_IN
        CD_NNP 36_CD protein_NN in_IN macrophages_NNS has_VBZ been_VBN associated_VBN with_IN increased_VBN uptake_NN of_IN ox-_NN LDL_NNP by_IN
        macrophages_NNS and_CC foam_NN cell_NN formation_NN in_IN atherosclerotic_JJ lesions_NNS in_IN people_NNS with_IN diabetes_NN
        [_NN 6_CD ,_, 9_CD ,_, 10_CD ]_NN ._. While_IN diabetic_JJ cardiovascular_JJ complications_NNS are_VBP closely_RB linked_VBN epidemiologically_RB
        with_IN albuminuria_NN and_CC DNP_NNP ,_, a_DT role_NN for_IN CD_NNP 36_CD in_IN DNP_NNP and_CC renal_JJ pathophysiology_NN has_VBZ not_RB to_TO our_PRP$
        knowledge_NN been_VBN described_VBN to_TO date_NN ._.
        Here_RB we_PRP report_VBP a_DT novel_NN functional_JJ role_NN for_IN CD_NNP 36_CD scavenger_NN receptor_NN and_CC AGE_NNP and_CC FFA_NNP
        palmitate_NN (_( PA_NNP )_) in_IN tubular_JJ epithelial_NN apoptosis_NNS associated_VBN with_IN TED_NNP and_CC progression_NN of_IN DNP_NNP ._.
        Specifically_RB ,_, we_PRP show_VBP that_IN glucose_NN stimulates_NNS CD_NNP 36_CD cell_NN surface_NN expression_NN in_IN proximal_NN
        tubular_JJ epithelial_NN cells_NNS (_( PTECs_NNP )_) ,_, and_CC increased_VBD CD_NNP 36_CD renders_NNS PTECs_NNP susceptible_JJ to_TO both_DT AGE-_NNP
        and_CC PA-induced_NNP PTEC_NNP apoptosis_NNS by_IN mediating_VBG sequential_NN activation_NN of_IN src_NN kinase_NN ,_,
        proapoptotic_JJ p_NN 38_CD MAPK_NNP ,_, and_CC caspase_NN 3_CD ._. Based_VBN on_IN these_DT findings_NNS ,_, we_PRP propose_VBP a_DT new_JJ two-step_JJ
        metabolic_JJ hit_NN model_NN for_IN TED_NNP in_IN the_DT progression_NN of_IN DNP_NNP ._.
      
      
        Methods_NNP
        
          Animals_NNS
          Kidneys_NNP were_VBD obtained_VBN from_IN 28_CD -_: wk-old_JJ C_NNP 57_CD BLKS_NNP /_NN J-_NNP lepr_NN
          db_NN /_NN db_NN ,_, STZ-treated_NNP C_NNP 57_CD BL_NNP /_NN 6_CD J_NNP ,_, or_CC STZ-treated_NNP 129_CD SvJ_NNP mice_NNS and_CC from_IN
          age-matched_JJ control_NN C_NNP 57_CD BLKS_NNP /_NN J-_NNP lepr_NN
          db_NN /_NN m_NN ,_, C_NNP 57_CD BL_NNP /_NN 6_CD J_NNP ,_, and_CC 129_CD SvJ_NNP mice_NNS as_IN described_VBN [_NN 5_CD ]_NN ._.
        
        
          Cell_NNP Culture_NNP
          Human_JJ proximal_NN tubular_JJ cell_NN line_NN HK-_NNP 2_CD and_CC murine_NN collecting_VBG duct_NN cell_NN line_NN M_NNP 1_CD were_VBD
          purchased_VBN from_IN American_NNP Type_NNP Culture_NNP Collection_NNP (_( Manassas_NNP ,_, Virginia_NNP ,_, United_NNP States_NNPS )_) and_CC
          cultured_JJ according_VBG to_TO the_DT vendor_NN 's_POS instructions_NNS ._. Mouse_NNP proximal_NN tubular_JJ cell_NN line_NN MCT_NNP was_VBD
          provided_VBN by_IN Fuad_NNP Ziyadeh_NNP (_( University_NNP of_IN Pennsylvania_NNP ,_, Philadelphia_NNP ,_, Pennsylvania_NNP ,_, United_NNP
          States_NNPS )_) ._. Transfections_NNP were_VBD performed_VBN with_IN Fugene_NNP 6_CD (_( Roche_NNP Diagnostics_NNPS ,_, Indianapolis_NNP ,_,
          Indiana_NNP ,_, United_NNP States_NNPS )_) according_VBG to_TO manufacturer_NN 's_POS protocol_NN ._. CD_NNP 36_CD -_: containing_VBG plasmid_NN was_VBD
          a_DT kind_NN gift_NN of_IN Nada_NNP Abumhrad_NNP (_( SUNY_NNP at_IN Stony_NNP Brook_NNP ,_, New_NNP York_NNP ,_, United_NNP States_NNPS )_) ._. Cells_NNP were_VBD
          also_RB co-transfected_JJ with_IN EGFP_NNP (_( Clontech_NNP ,_, Franklin_NNP Lakes_NNP ,_, New_NNP Jersey_NNP ,_, United_NNP States_NNPS )_) to_TO
          assess_VB transfection_NN efficiency_NN ._. Cells_NNP were_VBD serum_NN starved_VBN in_IN 0_CD ._. 2_CD %_NN serum_NN containing_VBG DMEM_NNP (_( 1_CD
          g_SYM /_NN l_NN glucose_NN )_) for_IN at_IN least_JJS 24_CD h_NN prior_RB to_TO stimulation_NN with_IN AGE–bovine_NNP serum_NN albumin_NN (_( BSA_NNP )_) ,_,
          glucose_NN ,_, or_CC FFA_NNP ._.
        
        
          Quantitative_NNP Real-_NNP Time_NNP PCR_NNP
          Quantitative_NNP real-time_JJ PCR_NNP analysis_NN of_IN mouse_NN and_CC human_JJ CD_NNP 36_CD ,_, HPRT_NNP 1_CD ,_, and_CC beta_NN actin_NN was_VBD
          performed_VBN as_IN described_VBN previously_RB [_NN 5_CD ]_NN ._. The_DT following_VBG primers_NNS were_VBD used_VBN :_: mouse_NN CD_NNP 36_CD 5_CD ′_NN
          TGCTGGAGCTGTTATTGGTG_NNP and_CC 3_CD ′_NN CATGAGAATGCCTCCAAACA_NNP ,_, mouse_NN beta_NN actin_NN 5_CD ′_NN
          ACCGTGAAAAGATGATGACCCAG_NNP and_CC 3_CD ′_NN AGCCTGGATGGCTACGTACA_NNP ,_, mouse_NN HPRT_NNP 1_CD 5_CD ′_NN TGTTGTTGGATATGCCCTTG_NNP
          and_CC 3_CD ′_NN TTGCGCTCATCTTAGGCTTT_NNP ,_, human_JJ CD_NNP 36_CD 5_CD ′_NN GCTCTGGGGCTACAAAGATG_NNP and_CC 3_CD ′_NN
          TAGGGAGAGATATCGGGCCT_NNP ,_, human_JJ beta_NN actin_NN 5_CD ′_NN GATGAGATTGGCATGGCTTT_NNP and_CC 3_CD ′_NN
          CACCTTCACCGTTCCAGTTT_NNP ,_, and_CC human_JJ HPRT_NNP 1_CD 5_CD ′_NN AAAGGACCCCACGAAGTGTT_NNP and_CC 3_CD ′_NN
          TCAAGGGCATATCCTACAACAA_NNP ._.
        
        
          Immunostaining_NNP and_CC Immunoblotting_NNP
          Primary_JJ antibodies_NNS specific_JJ for_IN the_DT following_VBG proteins_NNS were_VBD used_VBN :_: monoclonal_NN mouse_NN
          anti-_NN CD_NNP 36_CD antibody_NN ,_, clone_NN FA_NNP 6_CD –_NN 152_CD (_( IgG_NNP )_) (_( Immunotech_NNP ,_, Fullerton_NNP ,_, California_NNP ,_, United_NNP
          States_NNPS )_) ,_, clone_NN SMO_NNP (_( IgM_NNP )_) (_( Santa_NNP Cruz_NNP Biotechnology_NNP ,_, Santa_NNP Cruz_NNP ,_, California_NNP ,_, United_NNP
          States_NNPS )_) ,_, rabbit_NN polyclonal_NN anti-_NN CD_NNP 36_CD (_( Santa_NNP Cruz_NNP Biotechnology_NNP )_) ,_, rabbit_NN polyclonal_NN
          anti-aquaporin_JJ 1_CD ,_, anti-aquaporin_JJ 2_CD ,_, anti-_NN Na_NNP /_NN K_NNP /_NN 2_CD Cl_NNP (_( Chemicon_NNP ,_, Temecula_NNP ,_, California_NNP ,_, United_NNP
          States_NNPS )_) ,_, rabbit_NN polyclonal_NN phospho_NN 38_CD /_NN MAPK_NNP and_CC mouse_NN monoclonal_NN p_NN 38_CD (_( Cell_NNP Signaling_NNP
          Technology_NNP ,_, Beverly_NNP ,_, Massachusetts_NNP ,_, United_NNP States_NNPS )_) ,_, rabbit_NN polyclonal_NN p-src_JJ (_( Y_NNP 418_CD )_)
          (_( Biosource_NNP ,_, Camarillo_NNP ,_, California_NNP ,_, United_NNP States_NNPS )_) ,_, and_CC mouse_NN monoclonal_NN anti-tubulin_JJ
          (_( Sigma_NNP ,_, St_NNP ._. Louis_NNP ,_, Missouri_NNP ,_, United_NNP States_NNPS )_) ._. Immunostaining_NNP was_VBD performed_VBN on_IN frozen_VBN
          sections_NNS with_IN FITC-_NNP and_CC Cy_NNP 3_CD -_: labeled_VBN secondary_JJ antibodies_NNS (_( Jackson_NNP Laboratories_NNPS ,_, USA_NNP )_) ,_, or_CC
          on_IN paraffin-embedded_JJ sections_NNS with_IN immunoperoxidase_NN ,_, as_IN described_VBN earlier_JJR [_NN 5_CD ]_NN ._.
          Immunoblotting_NNP was_VBD performed_VBN with_IN 30_CD μg_NN of_IN protein_NN isolated_VBN from_IN cultured_JJ cells_NNS ._. Protein_NNP
          samples_NNS were_VBD resolved_VBN on_IN a_DT 10_CD %_NN SDS-PAGE_NNP and_CC immunoblotted_JJ with_IN primary_JJ antibody_NN and_CC
          revealed_VBD with_IN horse_NN radish_NN peroxidase_NN (_( HRP_NNP )_) -_: conjugated_JJ anti-mouse_JJ IgM_NNP ,_, or_CC anti-rabbit_JJ IgG_NNP
          (_( Jackson_NNP Laboratory_NNP ,_, Bar_NNP Harbor_NNP ,_, Maine_NNP ,_, United_NNP States_NNPS )_) ._. Immuncomplexes_NNP were_VBD detected_VBN by_IN
          enhanced_JJ chemiluminescence_NN (_( Pierce_NNP ,_, Rockford_NNP ,_, Illinois_NNP ,_, United_NNP States_NNPS )_) ._. The_DT proximal_NN
          tubular_JJ immunostaining_VBG was_VBD evaluated_VBN semi-quantitatively_JJ by_IN two_CD independent_JJ pathologists_NNS
          who_WP were_VBD unaware_JJ of_IN the_DT diagnosis_NN ;_: distribution_NN and_CC intensity_NN of_IN staining_VBG was_VBD scored_VBN on_IN a_DT
          ten-point_JJ scale_NN ._.
        
        
          Fluorescence_NNP Flow_NNP Cytometric_NNP Analysis_NNP
          Cells_NNP were_VBD incubated_JJ in_IN 0_CD ._. 5_CD mM_NN EDTA_NNP in_IN PBS_NNP at_IN 37_CD °_NN C_NNP for_IN 20_CD min_NN ,_, scraped_JJ ,_, and_CC then_RB
          washed_VBN with_IN 1_CD %_NN fetal_JJ bovine_JJ serum_NN ._. Cells_NNP were_VBD then_RB exposed_VBN to_TO monoclonal_NN anti-_NN CD_NNP 36_CD IgG_NNP
          FA_NNP 6_CD (_( 5_CD μg_NN /_NN ml_NN )_) ,_, or_CC control_NN mouse_NN IgG_NNP 1_CD (_( 5_CD μg_NN /_NN ml_NN )_) (_( Sigma_NNP )_) ,_, for_IN 45_CD min_NN on_IN ice_NN in_IN the_DT presence_NN
          of_IN 10_CD %_NN fetal_JJ bovine_JJ serum_NN then_RB washed_VBD with_IN PBS_NNP ._. This_DT was_VBD followed_VBN by_IN an_DT incubation_NN with_IN
          phycoerythrin-conjugated_JJ goat_NN anti-murine_JJ secondary_JJ antibody_NN (_( Southern_NNP Biotechnology_NNP ,_,
          Birmingham_NNP ,_, Alabama_NNP ,_, United_NNP States_NNPS )_) 1_CD :_: 50_CD for_IN 45_CD min_NN on_IN ice_NN ._. Cells_NNP (_( 1_CD ×_NN 10_CD
          4_LS )_) were_VBD analyzed_VBN by_IN using_VBG a_DT SCAN_NNP flow_NN cytometer_NN (_( BD_NNP ,_, Franklin_NNP Lakes_NNP ,_,
          New_NNP Jersey_NNP ,_, United_NNP States_NNPS )_) ,_, with_IN appropriate_JJ gating_VBG ._. Flow_NNP cytometry_NN data_NNS were_VBD analyzed_VBN
          using_VBG Cellquest_NNP (_( BD_NNP )_) ._.
        
        
          Preparation_NNP of_IN Glycated_NNP Albumin_NNP and_CC Carboxymethyl-_NNP Lysine_NNP Albumin_NNP
          Briefly_NNP ,_, to_TO prepare_VB AGE-BSA_NNP ,_, essentially_RB fatty-acid-free_JJ and_CC endotoxin-free_JJ BSA_NNP (_( 250_CD
          mg_NN /_NN ml_NN )_) was_VBD incubated_JJ at_IN 37_CD °_NN C_NNP for_IN 2_CD ,_, 5_CD ,_, and_CC 10_CD wk_NN with_IN D-_NNP glucose_NN (_( 500_CD mM_NN )_) in_IN a_DT 0_CD ._. 4_CD -_: M_NNP
          phosphate_NN buffer_NN containing_VBG EDTA_NNP ,_, ampicillin_NN ,_, Fungazone_NNP ,_, polymixin_NN B_NNP ,_, and_CC protease_NN
          inhibitors_NNS ._. Control_NN preparations_NNS were_VBD treated_VBN identically_RB except_IN that_DT glucose_NN was_VBD
          omitted_VBN ._. Carboxymethyl-lysine_NNP (_( CML_NNP )_) –_NN BSA_NNP was_VBD prepared_VBN as_IN described_VBN earlier_JJR [_NN 11_CD ]_NN ._. Briefly_NNP ,_,
          BSA_NNP with_IN minimal_JJ CML_NNP content_NN (_( CMLmin-BSA_NNP )_) was_VBD prepared_VBN by_IN incubation_NN of_IN BSA_NNP (_( 0_CD ._. 66_CD mM_NN )_)
          with_IN glyoxylic_JJ acid_NN (_( 2_CD ._. 15_CD mM_NN )_) in_IN the_DT presence_NN of_IN sodium_NN cyanoboronydrate_NN (_( 56_CD mM_NN )_) in_IN 200_CD
          mM_NN sodium_NN phosphate_NN buffer_NN (_( pH_NN 7_CD ._. 8_CD )_) at_IN 37_CD °_NN C_NNP under_IN aseptic_JJ conditions_NNS ._. Finally_RB ,_,
          preparations_NNS were_VBD extensively_RB dialyzed_JJ against_IN phosphate_NN buffer_NN to_TO remove_VB free_JJ glucose_NN ._.
          Preparations_NNP were_VBD then_RB tested_VBN for_IN the_DT presence_NN of_IN LPS_NNP with_IN a_DT Quantitative_NNP Chromogenic_NNP LAL_NNP
          kit_NN (_( Cambrex_NNP ,_, East_NNP Rutherford_NNP ,_, New_NNP Jersey_NNP ,_, United_NNP States_NNPS )_) ._. The_DT concentration_NN of_IN LPS_NNP was_VBD
          lower_JJR than_IN 0_CD ._. 07_CD IU_NNP /_NN mg_NN protein_NN in_IN all_DT preparations_NNS ._.
        
        
          Preparation_NNP of_IN FFA_NNP
          Palmitic_NNP acid_NN (_( P_NN 5585_CD )_) ,_, oleic_JJ acid_NN ,_, and_CC FFA-free_NNP low-endotoxin_JJ BSA_NNP (_( A_DT 8806_CD )_) were_VBD
          purchased_VBN from_IN Sigma_NNP ._. Palmitic_NNP acid_NN was_VBD dissolved_VBN at_IN 12_CD mM_NN in_IN PBS_NNP containing_VBG 11_CD %_NN
          fatty-acid-free_JJ BSA_NNP ,_, sonicated_JJ for_IN 5_CD min_NN ,_, shaken_VBN overnight_JJ at_IN 37_CD °_NN C_NNP ,_, and_CC sonicated_JJ for_IN 5_CD
          min_NN again_RB [_NN 12_CD ]_NN ._. For_IN control_NN experiments_NNS ,_, BSA_NNP in_IN the_DT absence_NN of_IN fatty_NN acids_NNS was_VBD prepared_VBN ,_,
          as_IN described_VBN above_IN ._. The_DT effective_JJ concentration_NN of_IN PA_NNP was_VBD determined_VBN using_VBG a_DT commercially_RB
          available_JJ kit_NN (_( Wako_NNP Chemicals_NNPS ,_, Neuss_NNP ,_, Germany_NNP )_) ._.
        
        
          Apoptosis_NNP Detection_NNP
          In_IN situ_NN detection_NN of_IN DNA_NNP fragmentation_NN was_VBD performed_VBN using_VBG the_DT ApoTag_NNP TUNEL_NNP assay_NN
          following_VBG the_DT manufacturer_NN 's_POS protocol_NN (_( Intergen_NNP ,_, Purchase_NNP ,_, New_NNP York_NNP ,_, United_NNP States_NNPS )_) [_NN 13_CD ]_NN ._.
          Apoptotic_NNP nuclei_NN were_VBD detected_VBN using_VBG DAPI_NNP staining_VBG (_( 1_CD μg_NN /_NN ml_NN ;_: 10_CD min_NN )_) in_IN cell_NN cultures_NNS
          fixed_VBN with_IN 4_CD %_NN paraformaldehyde_NN ,_, and_CC analyzed_VBD via_IN fluorescence_NN microscopy_NN to_TO assess_VB
          chromatin_NN condensation_NN and_CC segregation_NN ._. Caspase_NNP 3_CD activity_NN was_VBD detected_VBN by_IN using_VBG the_DT
          ApoAlert_NNP Caspase_NNP 3_CD Fluorescent_NNP Detection_NNP system_NN (_( BD_NNP )_) according_VBG to_TO the_DT manufacturer_NN 's_POS
          protocol_NN ._. Activity_NN was_VBD normalized_JJ to_TO total_VB protein_NN content_NN ._. Z-DEVD-_NNP fmk_NN ,_, z-_NN VAD-fmk_NNP ,_,
          z-_NN FA-fmk_NNP ,_, and_CC z-_NN LEHD-fmk_NNP were_VBD purchased_VBN from_IN BD_NNP ._.
        
        
          Human_NNP Kidney_NNP Biopsy_NNP Sample_NNP and_CC Patient_NNP Characteristics_NNP
          Human_JJ kidney_NN tissues_NNS (_( ten_CD controls_NNS ,_, ten_CD with_IN diabetic_JJ nephropathy_NN ,_, and_CC ten_CD with_IN focal_JJ
          segmental_NN glomerulosclerosis_NNS [_NN FSGS_NNP ]_NN )_) were_VBD obtained_VBN from_IN archived_JJ kidney_NN biopsy_NN samples_NNS or_CC
          from_IN discarded_VBN nephrectomy_NN specimens_NNS ._. All_DT diabetic_JJ samples_NNS were_VBD from_IN patients_NNS with_IN
          biopsy-proven_JJ advanced_VBD DNP_NNP with_IN serum_NN creatinine_NN ranging_VBG from_IN 1_CD ._. 7_CD to_TO 5_CD ._. 6_CD mg_NN /_NN dl_NN (_( 151_CD to_TO
          444_CD μM_NN /_NN l_NN )_) ,_, heavy_JJ proteinuria_NN (_( 3_CD +_NN by_IN dipstick_NN or_CC 3_CD –_NN 6_CD gr_NN /_NN d_SYM )_) ,_, and_CC hypertension_NN ._. All_DT patients_NNS
          with_IN FSGS_NNP were_VBD from_IN patients_NNS with_IN creatinine_NN levels_NNS of_IN 1_CD ._. 7_CD to_TO 4_CD ._. 9_CD mg_NN /_NN dl_NN (_( 151_CD to_TO 435_CD
          μM_NN /_NN l_NN )_) ,_, heavy_JJ proteinuria_NN (_( 3_CD +_NN by_IN dipstick_NN )_) ,_, and_CC hypertension_NN ._. The_DT diagnosis_NN of_IN FSGS_NNP was_VBD
          made_VBN on_IN Periodic_NNP acid–_NN Schiff_NNP staining_VBG in_IN the_DT absence_NN of_IN immunodeposits_NNS on_IN electron_NN
          microscopy_NN ._. The_DT diagnosis_NN of_IN diabetic_JJ nephropathy_NN was_VBD based_VBN on_IN the_DT presence_NN of_IN diabetes_NN ,_,
          proteinuria_NN ,_, and_CC the_DT characteristic_JJ light_JJ microscopy_NN findings_NNS ._. Institutional_NNP Review_NNP Board_NNP
          approval_NN was_VBD obtained_VBN for_IN procurement_NN of_IN kidney_NN specimens_NNS at_IN the_DT Thomas_NNP Jefferson_NNP
          University_NNP Hospital_NNP ._.
        
        
          Statistical_NNP Methods_NNP
          Data_NNP are_VBP reported_VBN as_IN mean_NN and_CC standard_JJ error_NN of_IN the_DT mean_NN (_( SEM_NNP )_) for_IN continuous_JJ
          variables_NNS ._. All_DT cell_NN culture_NN experiments_NNS were_VBD performed_VBN at_IN least_JJS three_CD times_NNS and_CC
          summarized_VBD ._. Standard_JJ software_NN packages_NNS (_( SPSS_NNP and_CC Excel_NNP for_IN Windows_NNP )_) were_VBD used_VBN to_TO provide_VB
          descriptive_JJ statistical_JJ plots_NNS (_( unpaired_JJ 
          t_NN -_: tests_NNS )_) ._. The_DT Bonferroni_NNP correction_NN was_VBD used_VBN for_IN multiple_JJ comparisons_NNS ._.
          Significance_NN for_IN the_DT quantification_NN of_IN the_DT CD_NNP 36_CD staining_VBG in_IN human_JJ biopsy_NN samples_NNS was_VBD
          calculated_VBN via_IN the_DT Wilcoxon_NNP Rank_NNP Sum_NNP Test_NNP ._.
        
      
      
        Results_NNS
        
          Increased_VBN Expression_NNP of_IN CD_NNP 36_CD Specifically_RB in_IN Proximal_NNP Tubules_NNP of_IN Human_NNP Diabetic_NNP
          Kidneys_NNP Is_VBZ Associated_NNP with_IN TED_NNP
          Using_VBG microarray-based_JJ gene_NN expression_NN profiling_VBG on_IN whole_JJ kidney_NN RNA_NNP together_RB with_IN
          supervised_JJ clustering_VBG methods_NNS ,_, we_PRP previously_RB identified_VBD and_CC validated_JJ gene_NN expression_NN
          patterns_NNS for_IN molecular_JJ classification_NN of_IN diabetic_JJ mice_NNS with_IN albuminuria_NN and_CC mesangial_NN
          expansion_NN [_NN 5_CD ]_NN ._. Reduced_NNP renal_JJ mRNA_NN levels_NNS of_IN the_DT class_NN B_NNP scavenger_NN receptor_NN CD_NNP 36_CD were_VBD
          characteristic_JJ for_IN diabetic_JJ mice_NNS with_IN albuminuria_NN [_NN 5_CD ]_NN ._. Here_RB we_PRP examined_VBD patterns_NNS of_IN CD_NNP 36_CD
          protein_NN expression_NN in_IN kidneys_NNS of_IN non-diabetic_JJ and_CC diabetic_JJ mice_NNS and_CC humans_NNS ._. CD_NNP 36_CD protein_NN
          was_VBD detectable_JJ in_IN the_DT thick_JJ ascending_VBG limb_NN of_IN loop_NN of_IN Henle_NNP and_CC in_IN the_DT collecting_VBG duct_NN ,_,
          and_CC absent_JJ in_IN proximal_NN tubules_NNS in_IN both_DT control_NN and_CC diabetic_JJ mouse_NN kidneys_NNS (_( Figure_NN 1_CD A–_NNP 1_CD D_NNP )_) ._.
          In_IN contrast_NN ,_, CD_NNP 36_CD was_VBD detectable_JJ only_RB rarely_RB in_IN individual_JJ proximal_NN tubular_JJ cells_NNS in_IN
          sections_NNS from_IN non-diabetic_JJ human_JJ kidneys_NNS (_( controls_NNS )_) (_( Figure_NN 1_CD E_NNP and_CC 1_CD H_NNP )_) ,_, but_CC was_VBD markedly_RB
          increased_VBN specifically_RB in_IN PTECs_NNP in_IN human_JJ diabetic_JJ kidneys_NNS (_( Figure_NN 1_CD F_NN and_CC 1_CD I_PRP )_) ._. In_IN
          addition_NN ,_, we_PRP did_VBD not_RB observe_VB increased_VBN proximal_NN tubular_JJ CD_NNP 36_CD expression_NN in_IN kidney_NN biopsy_NN
          samples_NNS from_IN patients_NNS with_IN FSGS_NNP (_( Figure_NN 1_CD J_NNP )_) ,_, that_WDT were_VBD matched_VBN with_IN DNP_NNP samples_NNS for_IN the_DT
          severity_NN of_IN proteinuria_NN (_( all_DT in_IN the_DT nephrotic_JJ range_NN )_) and_CC renal_JJ insufficiency_NN (_( all_DT with_IN
          elevated_JJ serum_NN creatinine_NN ;_: 1_CD ._. 7_CD –_NN 5_CD ._. 0_CD mg_NN /_NN dl_NN )_) ._. Semi-quantitative_NNP analysis_NN of_IN the_DT distribution_NN
          and_CC intensity_NN of_IN CD_NNP 36_CD -_: positive_JJ PTECs_NNP (_( CD_NNP 36_CD PTEC_NNP score_NN )_) ,_, which_WDT was_VBD performed_VBN by_IN two_CD
          independent_JJ pathologists_NNS in_IN a_DT blinded_JJ manner_NN ,_, demonstrated_VBN that_WDT mean_VBP CD_NNP 36_CD PTEC_NNP scores_NNS
          were_VBD not_RB different_JJ between_IN FSGS_NNP kidneys_NNS and_CC normal_JJ human_JJ kidneys_NNS ,_, but_CC were_VBD significantly_RB
          increased_VBN in_IN DNP_NNP kidneys_NNS (_( Figure_NN 1_CD K_NNP )_) ._.
          Periodic_NNP acid–_NN Schiff–stained_NNP sections_NNS of_IN kidneys_NNS from_IN mice_NNS exposed_VBN to_TO type_NN 2_CD diabetes_NN
          (_( db_NN /_NN db_NN mice_NNS )_) for_IN 20_CD wk_NN (_( Figure_NN 2_CD A_DT )_) ,_, or_CC type_NN 1_CD diabetes_NN (_( STZ-treated_NNP C_NNP 57_CD BL_NNP /_NN 6_CD J_NNP mice_NNS )_) for_IN 20_CD
          wk_NN (_( data_NNS not_RB shown_VBN )_) demonstrated_VBN moderate_JJ to_TO advanced_VBD mesangial_NN expansion_NN and_CC
          glomerulosclerosis_NNS (_( Figure_NN 2_CD A_DT )_) ._. Tubular_NNP abnormalities_NNS were_VBD not_RB detectable_JJ in_IN either_DT model_NN
          (_( Figure_NN 2_CD A_DT )_) ._. In_IN contrast_NN ,_, TED_NNP and_CC IF_IN were_VBD associated_VBN with_IN moderate_JJ to_TO advanced_VBD mesangial_NN
          expansion_NN and_CC glomerulosclerosis_NNS on_IN kidney_NN sections_NNS of_IN human_JJ DNP_NNP (_( Figure_NN 2_CD B_NNP )_) ._. These_DT
          findings_NNS indicate_VBP that_IN in_IN humans_NNS with_IN DNP_NNP ,_, diabetes-induced_JJ upregulation_NN of_IN CD_NNP 36_CD
          expression_NN in_IN proximal_NN tubules_NNS was_VBD associated_VBN with_IN moderate_JJ to_TO advanced_VBD stages_NNS of_IN TED_NNP and_CC
          IF_IN ._. In_IN contrast_NN ,_, in_IN diabetic_JJ mice_NNS with_IN albuminuria_NN ,_, mesangial_NN expansion_NN ,_, and_CC
          glomerulosclerosis_NNS ,_, absence_NN of_IN CD_NNP 36_CD expression_NN was_VBD associated_VBN with_IN normal_JJ appearance_NN of_IN
          the_DT tubular_JJ epithelium_NN and_CC interstitial_NN space_NN ._. These_DT findings_NNS suggest_VBP an_DT association_NN
          between_IN diabetes-induced_JJ proximal_NN tubular_JJ CD_NNP 36_CD expression_NN and_CC TED_NNP ._.
        
        
          Coincidence_NNP of_IN Increased_VBN CD_NNP 36_CD Expression_NNP and_CC Increased_VBN Tubular_NNP Epithelial_NNP Cell_NNP
          Apoptosis_NNP in_IN Human_NNP DNP_NNP
          CD_NNP 36_CD has_VBZ been_VBN shown_VBN to_TO mediate_VB apoptosis_NNS signaling_VBG induced_VBN by_IN TSP-_NNP 1_CD in_IN endothelial_NN
          cells_NNS [_NN 8_CD ]_NN and_CC by_IN ox-_NN LDL_NNP in_IN macrophages_NNS [_NN 14_CD ]_NN ._. We_PRP examined_VBD whether_IN the_DT strong_JJ upregulation_NN
          of_IN CD_NNP 36_CD protein_NN in_IN PTECs_NNP ,_, observed_VBD specifically_RB in_IN human_JJ DNP_NNP ,_, was_VBD associated_VBN with_IN tubular_JJ
          epithelial_NN cell_NN apoptosis_NNS in_IN vivo_NN ._. TUNEL-positive_NNP tubular_JJ epithelial_NN cells_NNS also_RB stained_JJ
          positive_NN for_IN CD_NNP 36_CD protein_NN (_( Figure_NN 2_CD D_NNP )_) and_CC aquaporin_NN 1_CD (_( Figure_NN 2_CD C_NNP )_) ,_, indicating_VBG that_IN
          apoptosis_NNS and_CC CD_NNP 36_CD expression_NN coincided_VBD in_IN PTECs_NNP in_IN human_JJ DNP_NNP ._. In_IN contrast_NN ,_, CD_NNP 36_CD was_VBD not_RB
          detectable_JJ in_IN TUNEL-positive_NNP PTECs_NNP in_IN non-diabetic_JJ FSGS_NNP kidneys_NNS and_CC in_IN normal_JJ human_JJ
          kidney_NN (_( data_NNS not_RB shown_VBN )_) ._. Statistical_NNP analysis_NN showed_VBD that_IN the_DT rate_NN of_IN TUNEL-positive_NNP
          tubular_JJ cells_NNS was_VBD significantly_RB increased_VBN in_IN kidneys_NNS of_IN human_JJ DNP_NNP compared_VBD with_IN normal_JJ
          control_NN human_JJ kidney_NN (_( Figure_NN 2_CD E_NNP )_) ._. In_IN addition_NN ,_, tubular_JJ epithelial_NN apoptosis_NNS was_VBD
          increased_VBN ,_, but_CC highly_RB variable_JJ ,_, in_IN FSGS_NNP kidneys_NNS (_( data_NNS not_RB shown_VBN )_) ._. In_IN contrast_NN ,_, tubular_JJ
          epithelial_NN apoptosis_NNS rates_NNS were_VBD comparable_JJ between_IN non-diabetic_JJ control_NN and_CC all_DT diabetic_JJ
          mouse_NN kidneys_NNS (_( Figure_NN 2_CD E_NNP )_) ._. The_DT diabetic_JJ mouse_NN group_NN included_VBD 24_CD -_: wk-old_JJ STZ-treated_NNP
          diabetic_JJ C_NNP 57_CD BL_NNP /_NN 6_CD J_NNP or_CC 129_CD SvJ_NNP mice_NNS (_( 0_CD ._. 23_CD ±_NN 0_CD ._. 1_CD TUNEL-positive_NNP cells_NNS per_IN 100_CD tubular_JJ cells_NNS )_)
          and_CC 24_CD -_: wk-old_JJ lepr_NN
          db_NN /_NN db_NN mice_NNS (_( 0_CD ._. 2_LS ±_NN 0_CD ._. 1_CD TUNEL-positive_NNP cells_NNS per_IN 100_CD tubular_JJ cells_NNS )_) ._.
          Together_RB ,_, these_DT findings_NNS indicate_VBP that_IN CD_NNP 36_CD expression_NN in_IN PTECs_NNP is_VBZ associated_VBN with_IN
          apoptotic_JJ events_NNS of_IN proximal_NN tubular_JJ cells_NNS and_CC TED_NNP specifically_RB in_IN human_JJ DNP_NNP ,_, but_CC not_RB in_IN
          FSGS_NNP with_IN matched_VBN functional_JJ and_CC clinical_JJ abnormalities_NNS ._. These_DT in_IN vivo_NN findings_NNS
          demonstrate_VBP a_DT strong_JJ association_NN of_IN diabetes-induced_JJ CD_NNP 36_CD expression_NN and_CC apoptosis_NNS in_IN
          PTECs_NNP in_IN human_JJ DNP_NNP ,_, suggesting_VBG that_IN CD_NNP 36_CD may_MD play_VB a_DT critical_JJ role_NN in_IN TED_NNP by_IN mediating_VBG
          PTEC_NNP apoptosis_NNS in_IN progressive_JJ human_JJ DNP_NNP ._.
        
        
          High_NNP Ambient_NNP Glucose_NNP Induces_NNP CD_NNP 36_CD Expression_NNP in_IN Human_NNP PTECs_NNP
          High_JJ ambient_NN glucose_NN has_VBZ been_VBN shown_VBN to_TO induce_VB CD_NNP 36_CD protein_NN synthesis_NN in_IN macrophages_NNS
          [_NN 9_CD ]_NN ._. Because_IN CD_NNP 36_CD protein_NN was_VBD markedly_RB increased_VBN in_IN proximal_NN tubules_NNS in_IN human_JJ DNP_NNP ,_, we_PRP
          examined_VBD the_DT effects_NNS of_IN high_JJ ambient_NN glucose_NN on_IN CD_NNP 36_CD mRNA_NN and_CC protein_NN expression_NN in_IN the_DT
          human_JJ PTEC_NNP line_NN HK-_NNP 2_CD (_( Figure_NN 3_LS )_) ._. Exposure_NNP of_IN cells_NNS to_TO 30_CD mM_NN D-_NNP glucose_NN for_IN 24_CD h_NN ,_, but_CC not_RB
          to_TO control_VB L-_NNP glucose_NN ,_, significantly_RB increased_VBN levels_NNS of_IN CD_NNP 36_CD mRNA_NN (_( Figure_NN 3_CD A_DT )_) ,_, CD_NNP 36_CD cell_NN
          surface_NN protein_NN (_( Figure_NN 3_CD C_NNP )_) ,_, and_CC CD_NNP 36_CD protein_NN expression_NN in_IN cell_NN lysates_NNS (_( Figure_NN 3_CD D_NNP )_) ._. In_IN
          contrast_NN ,_, CD_NNP 36_CD mRNA_NN and_CC protein_NN were_VBD not_RB detectable_JJ in_IN the_DT murine_NN PTEC_NNP line_NN MCT_NNP at_IN either_DT
          normal_JJ or_CC high_JJ ambient_NN glucose_NN concentrations_NNS (_( data_NNS not_RB shown_VBN )_) ._. Interestingly_RB ,_, glucose_NN
          stimulation_NN decreased_VBD CD_NNP 36_CD mRNA_NN levels_NNS (_( Figure_NN 3_CD B_NNP )_) and_CC CD_NNP 36_CD cell_NN surface_NN protein_NN (_( Figure_NN
          3_CD C_NNP )_) in_IN the_DT murine_NN collecting_VBG duct_NN cell_NN line_NN M_NNP 1_CD ,_, consistent_JJ with_IN our_PRP$ previously_RB reported_VBD
          findings_NNS in_IN diabetic_JJ mouse_NN kidney_NN [_NN 5_CD ]_NN ._. Exposure_NNP of_IN human_JJ HK-_NNP 2_CD and_CC murine_NN M_NNP 1_CD cell_NN lines_NNS to_TO
          defined_VBN preparations_NNS of_IN FFA_NNP PA_NNP or_CC AGE-BSA_NNP had_VBD no_DT effect_NN on_IN CD_NNP 36_CD mRNA_NN and_CC protein_NN
          expression_NN levels_NNS (_( data_NNS not_RB shown_VBN )_) ._. These_DT findings_NNS demonstrate_VBP that_IN high_JJ ambient_NN glucose_NN
          causes_NNS upregulation_NN of_IN CD_NNP 36_CD mRNA_NN and_CC protein_NN specifically_RB in_IN human_JJ ,_, but_CC not_RB in_IN mouse_NN ,_,
          PTECs_NNP ._. Together_RB with_IN our_PRP$ in_IN vivo_NN observations_NNS ,_, these_DT results_NNS suggest_VBP that_DT hyperglycemia_NN
          may_MD induce_VB upregulation_NN of_IN CD_NNP 36_CD mRNA_NN and_CC protein_NN selectively_RB in_IN proximal_NN tubules_NNS in_IN
          kidneys_NNS of_IN human_JJ DNP_NNP ,_, but_CC not_RB diabetic_JJ mice_NNS with_IN albuminuria_NN ._.
        
        
          AGE-BSA_NNP ,_, CML-BSA_NNP ,_, and_CC FFA_NNP PA_NNP Induce_NNP Apoptosis_NNP in_IN Human_NNP PTECs_NNP via_IN CD_NNP 36_CD
          AGE_NNP albumin_NN [_NN 15_CD ]_NN and_CC FFAs_NNP [_NN 16_CD ]_NN have_VBP been_VBN implicated_VBN in_IN the_DT pathogenesis_NNS of_IN diabetic_JJ
          complications_NNS ,_, including_VBG tubular_JJ degeneration_NN [_NN 17_CD ]_NN and_CC tubular_JJ epithelial-to-mesenchymal_JJ
          transition_NN [_NN 18_CD ]_NN ._. In_IN addition_NN ,_, AGE_NNP albumin_NN and_CC FFA_NNP are_VBP known_VBN to_TO interact_NN with_IN CD_NNP 36_CD
          [_NN 19_CD ,_, 20_CD ]_NN ._. However_RB ,_, it_PRP is_VBZ not_RB known_VBN whether_IN AGE_NNP and_CC /_NN or_CC FFA_NNP can_MD activate_VBP CD_NNP 36_CD signaling_VBG and_CC
          apoptosis_NNS in_IN tubular_JJ epithelial_NN cells_NNS ._. Treatment_NNP with_IN AGE-BSA_NNP for_IN 2_CD ,_, 5_CD ,_, or_CC 10_CD wk_NN or_CC with_IN
          CML-BSA_NNP induced_VBD a_DT significant_JJ increase_NN in_IN the_DT number_NN of_IN apoptotic_JJ nuclei_NN in_IN CD_NNP 36_CD -_: positive_JJ
          HK-_NNP 2_CD cells_NNS compared_VBN with_IN control_NN BSA-treated_NNP or_CC untreated_JJ HK-_NNP 2_CD cells_NNS (_( Figure_NN 4_CD A_DT )_) ._. In_IN
          contrast_NN ,_, AGE-BSA_NNP and_CC CML-BSA_NNP had_VBD no_DT effect_NN on_IN the_DT rate_NN of_IN apoptotic_JJ nuclei_NN in_IN
          CD_NNP 36_CD -_: negative_JJ murine_NN MCT_NNP PTECs_NNP (_( data_NNS not_RB shown_VBN )_) ._. Because_IN AGE-BSA_NNP glycated_JJ for_IN 5_CD wk_NN
          (_( AGE-BSA_NNP 5_LS )_) induced_VBN robust_JJ apoptosis_NNS at_IN concentrations_NNS between_IN 20_CD and_CC 40_CD μM_NN (_( Figure_NN 4_CD A_DT )_) ,_,
          we_PRP chose_VBD this_DT preparation_NN and_CC concentration_NN for_IN further_JJ analysis_NN in_IN all_DT subsequent_JJ
          experiments_NNS ._. AGE-BSA_NNP 5_CD -_: induced_VBN apoptosis_NNS was_VBD blocked_VBN when_WRB cells_NNS were_VBD preincubated_JJ with_IN
          neutralizing_VBG anti-_NN CD_NNP 36_CD antibody_NN ,_, while_IN preincubation_NN with_IN control_NN IgG_NNP antibody_NN had_VBD no_DT
          effect_NN (_( Figure_NN 4_CD A_DT )_) ._. These_DT results_NNS were_VBD confirmed_VBN by_IN DNA_NNP laddering_VBG assay_NN (_( data_NNS not_RB
          shown_VBN )_) ._.
          Among_IN the_DT most_RBS abundant_JJ glucose-modified_JJ proteins_NNS detectable_JJ in_IN the_DT plasma_NN of_IN diabetic_JJ
          individuals_NNS are_VBP CML_NNP proteins_NNS [_NN 21_CD ]_NN ,_, which_WDT are_VBP typically_RB present_JJ at_IN 1_CD ._. 6_CD to_TO 2_CD ._. 3_CD μM_NN
          concentrations_NNS in_IN the_DT plasma_NN and_CC urine_NN of_IN diabetic_JJ individuals_NNS [_NN 22_CD ,_, 23_CD ]_NN ._. To_TO use_VB
          physiologically_RB relevant_JJ CML_NNP proteins_NNS in_IN our_PRP$ in_IN vitro_NN experiments_NNS ,_, we_PRP prepared_VBD
          CMLmin-BSA_NNP ,_, characterized_VBN by_IN glycation_NN of_IN approximately_RB 30_CD %_NN of_IN lysine_NN residues_NNS [_NN 21_CD ]_NN ._. When_WRB
          applied_VBN to_TO HK-_NNP 2_CD PTECs_NNP at_IN concentrations_NNS ranging_VBG from_IN 0_CD ._. 5_CD to_TO 10_CD μM_NN ,_, CMLmin-BSA_NNP increased_VBD
          apoptosis_NNS rates_NNS significantly_RB (_( Figure_NN 4_CD B_NNP )_) ._. The_DT proapoptotic_JJ effect_NN of_IN CMLmin-BSA_NNP was_VBD
          blocked_VBN by_IN CD_NNP 36_CD neutralizing_VBG antibody_NN ,_, but_CC not_RB by_IN control_NN IgG_NNP (_( Figure_NN 4_CD B_NNP )_) ._.
          CD_NNP 36_CD has_VBZ been_VBN shown_VBN to_TO transport_VB fatty_NN acids_NNS in_IN adipocytes_NNS [_NN 24_CD ]_NN and_CC in_IN muscle_NN cells_NNS
          [_NN 25_CD ]_NN ._. Concentrations_NNP of_IN FFAs_NNP may_MD be_VB substantially_RB elevated_VBD ,_, to_TO levels_NNS of_IN up_IN to_TO 700_CD μM_NN ,_, in_IN
          individuals_NNS with_IN type_NN 2_CD diabetes_NN or_CC obesity_NN [_NN 26_CD ]_NN ._. Thus_RB ,_, we_PRP examined_VBD the_DT effects_NNS of_IN
          saturated_VBD FFA_NNP PA_NNP and_CC monounsaturated_JJ FFA_NNP oleate_NN on_IN apoptosis_NNS of_IN HK-_NNP 2_CD PTECs_NNP in_IN the_DT absence_NN
          or_CC presence_NN of_IN anti-_NN CD_NNP 36_CD neutralizing_VBG antibody_NN ._. PA_NNP significantly_RB increased_VBN rates_NNS of_IN
          apoptotic_JJ nuclei_NN in_IN a_DT concentration-dependent_JJ manner_NN in_IN HK-_NNP 2_CD PTECs_NNP (_( Figure_NN 4_CD C_NNP )_) ._. Anti-_NNP CD_NNP 36_CD
          neutralizing_VBG antibody_NN ,_, but_CC not_RB control_VB IgG_NNP ,_, blocked_VBD PA-induced_NNP apoptosis_NNS (_( Figure_NN 4_CD C_NNP )_) ._. In_IN
          contrast_NN ,_, oleate_NN did_VBD not_RB induce_VB apoptosis_NNS ,_, even_RB at_IN concentrations_NNS as_RB high_JJ as_IN 300_CD μM_NN
          (_( Figure_NN 4_CD C_NNP )_) ,_, neither_DT did_VBD it_PRP prevent_VBP PA-induced_NNP apoptosis_NNS (_( data_NNS not_RB shown_VBN )_) ._. Of_IN note_NN ,_, these_DT
          experiments_NNS were_VBD performed_VBN using_VBG a_DT total_JJ fatty_NN acid_NN :_: BSA_NNP ratio_NN of_IN 6_CD ._. 6_CD :_: 1_CD ,_, in_IN order_NN to_TO
          closely_RB model_VB pathophysiologic_JJ states_NNS in_IN which_WDT unbound_NN FFA_NNP concentration_NN is_VBZ high_JJ [_NN 27_CD ]_NN ._.
          Taken_VBN together_RB ,_, our_PRP$ findings_NNS demonstrate_VBP that_IN pathophysiologically_RB relevant_JJ species_NNS of_IN
          AGE-BSA_NNP and_CC CML-BSA_NNP ,_, as_RB well_RB as_IN saturated_VBN FFA_NNP PA_NNP ,_, induce_VB apoptosis_NNS in_IN human_JJ PTECs_NNP at_IN
          concentrations_NNS previously_RB observed_VBD in_IN plasma_NN and_CC /_NN or_CC urine_NN in_IN humans_NNS with_IN diabetes_NN ._.
        
        
          AGE-BSA_NNP and_CC PA_NNP Sequentially_NNP Activate_NNP src_NN kinase_NN ,_, Proapoptotic_NNP p_NN 38_CD MAPK_NNP ,_, and_CC Caspase_NNP
          3_CD through_IN CD_NNP 36_CD Receptor_NNP
          CD_NNP 36_CD has_VBZ previously_RB been_VBN shown_VBN to_TO trigger_VB the_DT activation_NN of_IN p_NN 59_CD fyn_NN ,_, p_NN 38_CD MAPK_NNP ,_, and_CC
          caspase_NN 3_CD (_( GeneID_NNP :_: 836_CD )_) in_IN response_NN to_TO thrombospondin_NN in_IN endothelial_NN cells_NNS [_NN 8_CD ]_NN ._. Therefore_RB
          we_PRP examined_VBD phospho-src_JJ ,_, phospho-p_JJ 38_CD levels_NNS and_CC caspase_NN 3_CD activation_NN in_IN HK-_NNP 2_CD PTECs_NNP
          treated_VBD with_IN AGE-BSA_NNP and_CC PA_NNP in_IN the_DT absence_NN or_CC presence_NN of_IN anti-_NN CD_NNP 36_CD neutralizing_VBG
          antibody_NN ._. Both_DT AGE-BSA_NNP 5_CD and_CC PA_NNP increased_VBD phospho-src_JJ levels_NNS rapidly_RB (_( after_IN as_RB little_JJ as_IN 5_CD
          min_NN )_) ,_, and_CC over_IN a_DT prolonged_JJ time_NN interval_NN (_( up_IN to_TO 3_CD h_NN )_) (_( Figure_NN 5_CD A_DT and_CC 5_CD B_NNP )_) ._. Phosphorylation_NNP
          of_IN src_NN kinase_NN was_VBD blocked_VBN by_IN anti-_NN CD_NNP 36_CD neutralizing_VBG antibody_NN (_( Figure_NN 5_CD A_DT and_CC 5_CD B_NNP )_) ._. This_DT
          observation_NN is_VBZ consistent_JJ with_IN previous_JJ findings_NNS demonstrating_VBG direct_JJ interaction_NN between_IN
          CD_NNP 36_CD and_CC p_NN 59_CD fyn_NN [_NN 8_CD ]_NN ;_: however_RB ,_, the_DT involvement_NN of_IN other_JJ src_NN kinases_NNS cannot_NN be_VB excluded_VBN ._. We_PRP
          also_RB observed_VBD increased_VBN levels_NNS of_IN phosphorylation_NN of_IN p_NN 38_CD MAPK_NNP beginning_VBG 1_CD to_TO 2_CD h_NN after_IN
          treatment_NN ,_, and_CC p_NN 38_CD activation_NN was_VBD also_RB completely_RB blocked_VBN by_IN anti-_NN CD_NNP 36_CD neutralizing_VBG
          antibody_NN (_( Figure_NN 5_CD C_NNP and_CC 5_CD D_NNP )_) ._. These_DT findings_NNS indicate_VBP that_IN CD_NNP 36_CD activates_NNS proapoptotic_JJ p_NN 38_CD
          MAPK_NNP possibly_RB via_IN src_NN kinase_NN activation_NN in_IN human_JJ PTECs_NNP when_WRB stimulated_VBN with_IN AGE-BSA_NNP 5_CD and_CC
          PA_NNP ._. Chemical_NN inhibition_NN of_IN p_NN 38_CD MAPK_NNP prevented_VBD the_DT increase_NN in_IN the_DT rate_NN of_IN apoptotic_JJ
          nuclei_NN induced_VBN by_IN both_DT AGE-BSA_NNP 5_CD and_CC PA_NNP in_IN HK-_NNP 2_CD PTECs_NNP (_( Figure_NN 5_CD G_NNP )_) ,_, indicating_VBG that_DT p_NN 38_CD
          MAPK_NNP function_NN is_VBZ required_VBN for_IN apoptosis_NNS induced_VBN by_IN AGE-BSA_NNP and_CC PA_NNP through_IN CD_NNP 36_CD receptor_NN ._.
          AGE-BSA_NNP and_CC PA_NNP significantly_RB increased_VBN activity_NN of_IN effector_NN caspase_NN 3_CD in_IN human_JJ PTECs_NNP
          (_( Figure_NN 5_CD E_NNP and_CC 5_CD F_NN )_) ._. Caspase_NNP 3_CD activation_NN was_VBD blocked_VBN by_IN anti-_NN CD_NNP 36_CD neutralizing_VBG antibody_NN ,_,
          but_CC not_RB by_IN control_NN IgG_NNP (_( Figure_NN 5_CD E_NNP and_CC 5_CD F_NN )_) ._. Pan-caspase_NNP inhibitor_NN z-_NN VAD-fmk_NNP and_CC the_DT
          specific_JJ caspase_NN 3_CD inhibitor_NN z-_NN DEVD-fmk_NNP prevented_VBD apoptosis_NNS induced_VBN by_IN PA_NNP and_CC AGE-BSA_NNP ,_,
          while_IN the_DT specific_JJ caspase_NN 9_CD inhibitor_NN z-_NN LEHD-fmk_NNP had_VBD no_DT significant_JJ inhibitor_NN effect_NN
          (_( Figure_NN 5_CD G_NNP )_) ._. Together_RB these_DT findings_NNS indicate_VBP that_IN CD_NNP 36_CD receptor_NN mediates_NNS sequential_NN
          phosphorylation_NN of_IN src_NN kinases_NNS and_CC p_NN 38_CD MAPK_NNP ,_, leading_VBG to_TO activation_NN of_IN caspase_NN 3_CD and_CC
          apoptosis_NNS in_IN human_JJ PTECs_NNP exposed_VBD to_TO AGE-BSA_NNP and_CC PA_NNP ligands_NNS ._. Interestingly_RB ,_, we_PRP did_VBD not_RB
          observe_VB phosphorylation_NN of_IN Smad_NNP 2_CD and_CC p_NN 42_CD /_NN 44_CD ERK_NNP MAPK_NNP under_IN these_DT conditions_NNS ,_, as_RB
          previously_RB reported_VBD for_IN AGE_NNP binding_VBG to_TO the_DT RAGE_NNP receptor_NN [_NN 28_CD ]_NN ._.
        
        
          CD_NNP 36_CD Is_VBZ Sufficient_NNP to_TO Mediate_NNP Apoptosis_NNP Induced_NNP by_IN AGE-BSA_NNP and_CC FFA_NNP
          In_IN contrast_NN with_IN CD_NNP 36_CD -_: positive_JJ human_JJ HK-_NNP 2_CD PTECs_NNP ,_, we_PRP found_VBD that_DT treatment_NN of_IN
          CD_NNP 36_CD -_: negative_JJ mouse_NN MCT_NNP PTECs_NNP with_IN AGE-BSA_NNP had_VBD no_DT effect_NN on_IN rates_NNS of_IN apoptotic_JJ nuclei_NN
          (_( data_NNS not_RB shown_VBN )_) ._. To_TO test_VB whether_IN CD_NNP 36_CD was_VBD sufficient_JJ to_TO mediate_VB AGE-BSA-induced_NNP
          apoptosis_NNS ,_, we_PRP transfected_JJ CD_NNP 36_CD -_: negative_JJ mouse_NN MCT_NNP PTECs_NNP with_IN a_DT plasmid_NN expressing_VBG human_JJ
          CD_NNP 36_CD or_CC empty_JJ control_NN vector_NN ,_, followed_VBN by_IN treatment_NN with_IN control_NN BSA_NNP or_CC AGE-BSA_NNP 5_CD ._.
          AGE-BSA_NNP 5_CD treatment_NN had_VBD no_DT significant_JJ effect_NN on_IN rates_NNS of_IN apoptotic_JJ nuclei_NN in_IN MCT_NNP PTECs_NNP
          transfected_JJ with_IN control_NN vector_NN (_( Figure_NN 6_CD )_) ._. In_IN contrast_NN ,_, AGE-BSA_NNP significantly_RB increased_VBD
          apoptotic_JJ nuclei_NN compared_VBN with_IN unglycated_JJ BSA_NNP in_IN MCT_NNP PTECs_NNP transiently_RB transfected_JJ with_IN
          CD_NNP 36_CD expression_NN vector_NN (_( Figure_NN 6_CD )_) ._. Nonglycated_NNP control_NN albumin_NN did_VBD not_RB cause_VB apoptosis_NNS ._.
          Thus_RB ,_, transgenic_JJ de_IN novo_NN expression_NN of_IN human_JJ CD_NNP 36_CD in_IN CD_NNP 36_CD -_: negative_JJ mouse_NN PTECs_NNP was_VBD
          sufficient_JJ to_TO mediate_VB apoptosis_NNS induced_VBN by_IN AGE-BSA_NNP ._.
        
      
      
        Discussion_NNP
        Advanced_NNP diabetic_JJ nephropathies_NNS in_IN humans_NNS with_IN type_NN 1_CD or_CC type_NN 2_CD diabetes_NN are_VBP uniformly_RB
        characterized_VBN by_IN TED_NNP ,_, or_CC tubular_JJ atrophy_NN ,_, and_CC IF_IN leading_VBG to_TO renal_JJ failure_NN [_NN 29_CD ,_, 30_CD ]_NN ._. Although_IN
        TED_NNP and_CC IF_IN are_VBP the_DT strongest_JJS predictors_NNS for_IN progression_NN of_IN DNP_NNP [_NN 31_CD ]_NN ,_, mechanisms_NNS that_WDT
        underlie_VB TED_NNP in_IN DNP_NNP remain_VB poorly_RB understood_VBN ._. Based_VBN on_IN our_PRP$ in_IN vitro_NN and_CC in_IN vivo_NN findings_NNS we_PRP
        propose_VBP a_DT two-step_JJ metabolic_JJ hit_NN model_NN for_IN TED_NNP in_IN DNP_NNP ._. High_JJ ambient_NN glucose_NN ,_, but_CC not_RB AGE_NNP or_CC
        FFA_NNP ,_, cause_VB stimulation_NN of_IN CD_NNP 36_CD expression_NN in_IN PTECs_NNP specifically_RB in_IN diabetic_JJ kidneys_NNS ._.
        Increased_VBN CD_NNP 36_CD expression_NN mediates_NNS sequential_NN activation_NN of_IN src_NN kinase_NN ,_, proapoptotic_JJ p_NN 38_CD
        MAPK_NNP ,_, and_CC caspase_NN 3_CD in_IN PTECs_NNP in_IN the_DT presence_NN of_IN AGE_NNP and_CC FFA_NNP PA_NNP ,_, resulting_VBG in_IN PTEC_NNP
        apoptosis_NNS ._. Proximal_NNP tubular_JJ epithelial_NN apoptosis_NNS may_MD be_VB an_DT initial_JJ mechanism_NN for_IN TED_NNP in_IN
        DNP_NNP ._.
        Our_PRP$ conclusions_NNS are_VBP supported_VBN by_IN several_JJ key_JJ observations_NNS ._. First_LS ,_, we_PRP identify_VBP a_DT new_JJ
        functional_JJ role_NN for_IN CD_NNP 36_CD as_IN an_DT essential_JJ mediator_NN of_IN proximal_NN tubular_JJ epithelial_NN apoptosis_NNS ,_,
        inducible_JJ by_IN AGE-BSA_NNP ,_, CMLmin-BSA_NNP ,_, and_CC FFA_NNP PA_NNP ._. Previous_JJ reports_NNS demonstrated_VBD a_DT role_NN for_IN CD_NNP 36_CD
        in_IN mediating_VBG apoptosis_NNS induced_VBN by_IN TSP-_NNP 1_CD in_IN endothelial_NN cells_NNS and_CC ox-_NN LDL_NNP in_IN macrophages_NNS
        [_NN 8_CD ,_, 14_CD ]_NN ._. In_IN the_DT present_JJ study_NN ,_, we_PRP show_VBP for_IN the_DT first_JJ time_NN ,_, to_TO our_PRP$ knowledge_NN ,_, that_IN CD_NNP 36_CD
        mediates_NNS apoptosis_NNS in_IN differentiated_JJ epithelial_NN cells_NNS that_WDT are_VBP exposed_VBN to_TO AGE-BSA-_NNP ,_,
        CMLmin-BSA-_NNP ,_, and_CC FFA-induced_NNP metabolic_JJ injury_NN characteristic_NN of_IN the_DT diabetic_JJ milieu_NN ._.
        Interestingly_RB ,_, AGE_NNP albumins_NNS and_CC CML_NNP are_VBP present_JJ in_IN the_DT urine_NN of_IN individuals_NNS with_IN diabetes_NN
        with_IN albuminuria_NN due_JJ to_TO DNP_NNP and_CC have_VBP been_VBN shown_VBN to_TO bind_NN proximal_NN tubular_JJ epithelium_NN
        [_NN 22_CD ,_, 32_CD ]_NN ._. While_IN the_DT presence_NN or_CC absence_NN of_IN FFAs_NNP in_IN the_DT urine_NN of_IN diabetics_NNS with_IN DNP_NNP has_VBZ not_RB
        been_VBN determined_VBN to_TO date_NN ,_, FFAs_NNP may_MD cause_VB tubular_JJ apoptosis_NNS [_NN 33_CD ]_NN ._. It_PRP remains_VBZ to_TO be_VB determined_VBN
        whether_IN FFA_NNP interacts_NNS with_IN CD_NNP 36_CD to_TO activate_VBP CD_NNP 36_CD receptor_NN signaling_VBG ,_, or_CC whether_IN CD_NNP 36_CD
        mediates_NNS FFA_NNP uptake_NN to_TO activate_VBP src_NN kinase_NN and_CC p_NN 38_CD MAPK_NNP signaling_VBG ._. Irrespective_NNP of_IN the_DT
        upstream_JJ mechanism_NN of_IN FFA_NNP and_CC CD_NNP 36_CD interaction_NN ,_, our_PRP$ results_NNS demonstrate_VBP very_RB rapid_JJ
        activation_NN of_IN a_DT well-characterized_JJ intracellular_NN kinase_NN cascade_NN of_IN proapoptotic_JJ signaling_VBG ._.
        Our_PRP$ finding_VBG that_IN AGE-BSA_NNP and_CC PA_NNP induce_VB apoptosis_NNS through_IN a_DT CD_NNP 36_CD -_: mediated_JJ and_CC p_NN 38_CD -_: and_CC
        caspase-dependent_JJ mechanism_NN in_IN tubular_JJ epithelial_NN cells_NNS ,_, similar_JJ to_TO TSP-_NNP 1_CD and_CC ox-_NN LDL_NNP in_IN
        endothelial_NN cells_NNS and_CC macrophages_NNS ,_, respectively_RB ,_, suggests_VBZ that_IN multiple_JJ ,_, context-dependent_JJ
        extracellular_NN stimuli_NNS of_IN apoptosis_NNS may_MD converge_NN on_IN CD_NNP 36_CD scavenger_NN receptor_NN to_TO activate_VBP src_NN
        kinase_NN and_CC proapoptotic_JJ p_NN 38_CD MAPK_NNP pathway_NN ._. In_IN the_DT context_NN of_IN the_DT diabetic_JJ milieu_NN and_CC
        diabetic_JJ complications_NNS ,_, our_PRP$ findings_NNS provide_VBP new_JJ molecular_JJ insights_NNS into_IN diabetes-induced_JJ
        AGE-_NNP and_CC FFA-dependent_NNP injury_NN of_IN renal_JJ epithelial_NN cells_NNS ._.
        Almost_RB all_DT TUNEL-positive_NNP apoptotic_JJ tubular_JJ epithelial_NN cells_NNS showed_VBD increased_VBN expression_NN
        of_IN CD_NNP 36_CD ,_, suggesting_VBG a_DT strong_JJ correlation_NN between_IN upregulation_NN of_IN CD_NNP 36_CD expression_NN and_CC
        increased_VBN apoptosis_NNS in_IN PTECs_NNP specifically_RB in_IN human_JJ diabetic_JJ kidney_NN in_IN vivo_NN ._. Importantly_NNP ,_,
        biopsy_NN samples_NNS from_IN cases_NNS of_IN FSGS_NNP that_WDT were_VBD matched_VBN for_IN degree_NN of_IN proteinuria_NN ,_, renal_JJ
        function_NN ,_, and_CC hypertension_NN were_VBD characterized_VBN by_IN TED_NNP ,_, IF_IN ,_, and_CC increased_VBD tubular_JJ epithelial_NN
        apoptosis_NNS ;_: however_RB ,_, proximal_NN tubular_JJ CD_NNP 36_CD expression_NN was_VBD similar_JJ to_TO that_DT in_IN normal_JJ human_JJ
        control_NN kidney_NN ._. Therefore_RB ,_, CD_NNP 36_CD expression_NN in_IN PTECs_NNP is_VBZ specifically_RB associated_VBN with_IN the_DT
        diabetic_JJ condition_NN and_CC appears_VBZ to_TO be_VB independent_JJ of_IN degree_NN of_IN proteinuria_NN and_CC renal_JJ
        failure_NN ._. Indeed_RB ,_, increased_VBD CD_NNP 36_CD expression_NN in_IN PTECs_NNP in_IN human_JJ DNP_NNP in_IN vivo_NN may_MD be_VB caused_VBN by_IN
        hyperglycemia_NN ,_, as_IN we_PRP show_VBP that_IN high_JJ glucose_NN concentration_NN stimulates_NNS CD_NNP 36_CD expression_NN in_IN
        vitro_NN ._. It_PRP is_VBZ intriguing_JJ that_IN CD_NNP 36_CD expression_NN was_VBD not_RB detected_VBN in_IN PTECs_NNP in_IN diabetic_JJ mice_NNS
        with_IN longstanding_JJ hyperglycemia_NN in_IN vivo_NN ,_, although_IN underlying_VBG mechanisms_NNS for_IN the_DT
        species-dependent_JJ differential_NN regulation_NN of_IN CD_NNP 36_CD in_IN PTECs_NNP in_IN vivo_NN and_CC in_IN vitro_NN between_IN
        mouse_NN and_CC human_JJ remain_VB unclear_JJ at_IN this_DT time_NN ._. Comparisons_NNP of_IN human_JJ 
        CD_NNP 36_CD and_CC mouse_NN 
        Cd_NNP 36_CD genes_NNS indicate_VBP a_DT high_JJ degree_NN of_IN sequence_NN and_CC structural_JJ similarity_NN
        in_IN both_DT coding_VBG and_CC regulatory_JJ regions_NNS ,_, suggesting_VBG that_IN the_DT mechanism_NN or_CC mechanisms_NNS that_WDT
        underlie_VB our_PRP$ findings_NNS are_VBP likely_RB determined_VBN by_IN sequence-independent_JJ ,_, epigenetically_RB
        distinct_JJ response_NN patterns_NNS to_TO the_DT diabetic_JJ milieu_NN that_WDT differ_VBP between_IN these_DT species_NNS ._. It_PRP is_VBZ
        also_RB possible_JJ that_IN dietary_JJ or_CC metabolic_JJ factors_NNS account_VBP for_IN the_DT differences_NNS in_IN CD_NNP 36_CD
        expression_NN ,_, as_IN mice_NNS were_VBD maintained_VBN on_IN standard_JJ mouse_NN chow_NN characterized_VBN by_IN significantly_RB
        lower_JJR fat_NN and_CC cholesterol_NN contents_NNS than_IN typical_JJ western_JJ diets_NNS consumed_VBN by_IN humans_NNS ._. However_RB ,_,
        dietary_JJ or_CC other_JJ unknown_JJ environmental_JJ factors_NNS cannot_NN explain_VBP the_DT differential_JJ CD_NNP 36_CD
        regulation_NN by_IN glucose_NN in_IN human_NN and_CC mouse_NN PTECs_NNP ._. Thus_RB ,_, we_PRP are_VBP exploring_VBG whether_IN biochemical_JJ
        or_CC functional_JJ differences_NNS between_IN mouse_NN and_CC human_JJ PTECs_NNP in_IN glucose_NN metabolism_NN or_CC
        glucose-induced_JJ signaling_VBG can_MD be_VB identified_VBN ._. However_RB ,_, current_JJ lack_NN of_IN understanding_NN of_IN the_DT
        observed_VBN differential_NN regulation_NN between_IN human_NN and_CC mouse_NN does_VBZ not_RB diminish_VB the_DT
        translational_NN research_NN significance_NN of_IN our_PRP$ findings_NNS ,_, with_IN their_PRP$ clear_JJ therapeutic_JJ
        implications_NNS ._. Thus_RB ,_, the_DT present_JJ study_NN identifies_VBZ a_DT new_JJ CD_NNP 36_CD -_: dependent_JJ molecular_JJ signaling_VBG
        pathway_NN that_WDT mediates_NNS tubular_JJ epithelial_NN apoptosis_NNS ,_, and_CC may_MD underlie_VB TED_NNP and_CC IF_IN ,_, hallmarks_NNS
        of_IN disease_NN progression_NN ,_, specifically_RB in_IN human_JJ diabetic_JJ nephropathy_NN ._.
        Third_NNP ,_, to_TO our_PRP$ knowledge_NN ,_, our_PRP$ report_NN provides_VBZ the_DT first_JJ controlled_VBN study_NN demonstrating_VBG
        increased_VBN apoptosis_NNS specifically_RB in_IN PTECs_NNP in_IN DNP_NNP with_IN TED_NNP and_CC IF_IN ._. These_DT findings_NNS are_VBP
        consistent_JJ with_IN a_DT recent_JJ uncontrolled_JJ case_NN series_NN of_IN five_CD patients_NNS with_IN DNP_NNP [_NN 34_CD ]_NN ,_, and_CC with_IN
        previous_JJ reports_NNS demonstrating_VBG tubular_JJ apoptosis_NNS in_IN kidneys_NNS of_IN STZ-treated_NNP diabetic_JJ rats_NNS
        [_NN 35_CD ,_, 36_CD ]_NN ._. Interestingly_RB ,_, our_PRP$ study_NN shows_VBZ that_IN tubular_JJ epithelial_NN apoptosis_NNS was_VBD associated_VBN
        with_IN TED_NNP and_CC IF_IN in_IN human_JJ DNP_NNP ,_, while_IN normal_JJ appearance_NN of_IN tubular_JJ epithelium_NN and_CC
        interstitium_NN was_VBD associated_VBN with_IN baseline_NN apoptosis_NNS rates_NNS in_IN diabetic_JJ mouse_NN models_NNS ._.
        Together_RB ,_, published_VBN observations_NNS from_IN experimental_JJ diabetes_NN models_NNS in_IN mouse_NN and_CC rat_NN ,_, and_CC
        human_JJ DNP_NNP ,_, and_CC our_PRP$ own_JJ findings_NNS in_IN diabetic_JJ mouse_NN models_NNS and_CC human_JJ DNP_NNP ,_, suggest_VBP a_DT striking_JJ
        association_NN of_IN TED_NNP and_CC tubular_JJ epithelial_NN apoptosis_NNS ._. However_RB ,_, whether_IN tubular_JJ epithelial_NN
        apoptosis_NNS causes_NNS TED_NNP in_IN DNP_NNP will_MD require_VB further_JJ investigation_NN ._. Interestingly_RB ,_, acute_JJ and_CC
        chronic_JJ chemical_NN inhibition_NN of_IN caspase_NN activity_NN in_IN a_DT nephrotoxic_JJ serum_NN nephritis_NNS model_NN of_IN
        chronic_JJ progressive_JJ glomerulonephritis_NNS with_IN TED_NNP and_CC IF_IN reduced_VBN tubular_JJ apoptosis_NNS and_CC TED_NNP
        [_NN 37_CD ]_NN ._. Decreased_NNP tubular_JJ apoptosis_NNS and_CC TED_NNP were_VBD associated_VBN with_IN significantly_RB reduced_VBN IF_IN and_CC
        decreased_VBD collagen_NN synthesis_NN in_IN this_DT model_NN ._. This_DT finding_VBG suggests_VBZ that_IN tubular_JJ epithelial_NN
        apoptosis_NNS may_MD trigger_VB TED_NNP and_CC IF_IN in_IN this_DT model_NN of_IN chronic_JJ glomerulonephritis_NNS in_IN rat_NN ,_, and_CC
        supports_VBZ our_PRP$ conclusions_NNS that_IN diabetes-induced_JJ tubular_JJ epithelial_NN apoptosis_NNS may_MD underlie_VB
        TED_NNP associated_VBN with_IN IF_IN in_IN human_JJ DNP_NNP ._.
        In_IN conclusion_NN ,_, we_PRP report_VBP a_DT new_JJ functional_JJ role_NN for_IN CD_NNP 36_CD scavenger_NN receptor_NN in_IN tubular_JJ
        epithelial_NN apoptosis_NNS associated_VBN with_IN tubular_JJ degeneration_NN and_CC progression_NN of_IN DNP_NNP ._.
        Specifically_RB ,_, we_PRP show_VBP for_IN the_DT first_JJ time_NN that_IN both_DT AGE_NNP and_CC FFA_NNP PA_NNP induce_VB PTEC_NNP apoptosis_NNS
        through_IN CD_NNP 36_CD -_: mediated_JJ activation_NN of_IN src_NN kinase_NN ,_, p_NN 38_CD MAPK_NNP ,_, and_CC caspase_NN 3_CD ._. Because_IN high_JJ
        glucose_NN stimulates_NNS CD_NNP 36_CD expression_NN in_IN human_JJ PTECs_NNP and_CC because_IN CD_NNP 36_CD expression_NN is_VBZ increased_VBN
        in_IN apoptotic_JJ tubular_JJ epithelial_NN cells_NNS in_IN human_JJ DNP_NNP ,_, we_PRP propose_VBP a_DT two-step_JJ metabolic_JJ hit_NN
        model_NN relevant_JJ for_IN TED_NNP ,_, a_DT hallmark_NN of_IN progression_NN of_IN human_JJ DNP_NNP ._.
      
      
        Supporting_VBG Information_NNP
        
          Accession_NNP Numbers_NNPS
          The_DT LocusLink_NNP (_( http_NN :_: /_NN /_NN www_NN ._. ncbi_NN ._. nlm_NN ._. nih_NN ._. gov_NN /_NN LocusLink_NNP /_NN )_) accession_NN numbers_NNS for_IN the_DT gene_NN
          products_NNS discussed_VBN in_IN this_DT paper_NN are_VBP caspase_NN 3_CD (_( GeneID_NNP :_: 836_CD )_) ,_, CD_NNP 36_CD (_( GeneID_NNP :_: 948_CD )_) ,_, MAPK_NNP
          (_( GeneID_NNP :_: 1432_CD )_) ,_, p_NN 42_CD /_NN 44_CD ERK_NNP MAPK_NNP (_( GeneID_NNP :_: 50689_CD )_) ,_, p_NN 59_CD fyn_NN (_( GeneID_NNP :_: 2534_CD )_) ,_, and_CC Smad_NNP 2_CD
          (_( GeneID_NNP :_: 4087_CD )_) ._.
        
      
    
  
